Peter A. Raven

Level 6, 2775-Laurel St
Vancouver, BC V5Z1M9, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.

Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 06, 2019

Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.

Development of a murine intravesical orthotopic human bladder cancer (mio-hBC) model.

Journal: American journal of clinical and experimental urology

Published: October 31, 2018

Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer.

Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer.

Journal: Journal of cellular physiology

Published: August 30, 2018

Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients.

Identification of hypoxic gene-signature as a prognostic and predictive biomarker to determine effective therapy in high risk bladder cancer patients.

Journal: Translational andrology and urology

Published: April 13, 2018

Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma.

Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma.

Journal: Oncotarget

Published: December 21, 2017

Orthotopic Mouse Models of Urothelial Cancer.

Orthotopic Mouse Models of Urothelial Cancer.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: September 11, 2017

Magnetically-actuated drug delivery device (MADDD) for minimally invasive treatment of prostate cancer: An in vivo animal pilot study.

Magnetically-actuated drug delivery device (MADDD) for minimally invasive treatment of prostate cancer: An in vivo animal pilot study.

Journal: The Prostate

Published: June 29, 2017

The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib.

The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib.

Journal: Oncotarget

Published: June 20, 2017

Effect of contrast media on urinary cytopathology specimens.

Effect of contrast media on urinary cytopathology specimens.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: November 24, 2016

Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma.

Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma.

Journal: Neoplasia (New York, N.Y.)

Published: July 19, 2015

Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma.

Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell Carcinoma.

Journal: Molecular cancer therapeutics

Published: September 10, 2014

Growth and endocrine effects of recombinant bovine growth hormone treatment in non-transgenic and growth hormone transgenic coho salmon.

Growth and endocrine effects of recombinant bovine growth hormone treatment in non-transgenic and growth hormone transgenic coho salmon.

Journal: General and comparative endocrinology

Published: December 19, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026